1. BMPR2 mutation is linked to PAH pathology.
2. Inflammation is central to PAH pathogenesis.
3. iPSC-derived endothelial cells can be used to screen new PAH therapies.
Friday, September 8, 2017 - 12:00pm to 1:00pm
Add to calendar:
Chicago, IL 60637
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation